|
Market Closed -
Toronto S.E.
16:00:00 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 11.70 CAD | +2.18% |
|
+10.27% | +93.39% |
| 10-06 | Knight Therapeutics Inc. Receives Expedited Regulatory Approval Under ANVISA?s Rare Disease Pathway For NIKTIMVO® In Brazil | CI |
| 10-06 | Knight Therapeutics Strengthens Portfolio in Brazil | MT |
| Market Cap | 1.12B 800M 713M 660M 597M 75.46B 1.14B 7.91B 3.1B 39.66B 3B 2.94B 126B | P/E 2026 * |
82.8x | P/E 2027 * | 43x |
|---|---|---|---|---|---|
| Enterprise Value | 1.12B 800M 713M 660M 597M 75.46B 1.14B 7.91B 3.1B 39.66B 3B 2.94B 126B | EV / Sales 2026 * |
2.04x | EV / Sales 2027 * | 2.03x |
| Free-Float |
54% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| GUD | Delayed | |
OTC Markets
| KHTRF | Delayed | |
|
Deutsche Boerse AG
| 04K | Delayed | |
|
Tradegate
| 04K | Real-time | |
|
Boerse Muenchen
| 04K | Real-time | |
|
Börse Stuttgart
| 04K | Delayed |
Last Transcript: Knight Therapeutics Inc.
| 1 day | +2.18% | ||
| 1 week | +10.27% | ||
| Current month | +10.48% | ||
| 1 month | +14.93% | ||
| 3 months | +17.35% | ||
| 6 months | +57.68% | ||
| Current year | +93.39% |
| 1 week | 10.58 |  | 11.71 |
| 1 month | 10.01 | | 11.71 |
| Current year | 5.66 | | 11.71 |
| 1 year | 5.66 | | 11.71 |
| 3 years | 4.35 | | 11.71 |
| 5 years | 4.28 | | 11.71 |
| 10 years | 4.28 | | 11.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 57 | 2021-08-31 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 2020-03-29 |
Melanie Groleau
CTO | Chief Tech/Sci/R&D Officer | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan Goodman
CHM | Chairman | 58 | 2021-08-31 |
James Gale
CHM | Chairman | 77 | - |
Robert Lande
BRD | Director/Board Member | 63 | 2012-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 | Option | 722 | 0.0007% | - | ||
| 9/15/26 | Option | Head of Human Resources | 714 | 0.0007% | ||
| 9/15/26 | Option | Founder | 587 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.18% | +10.27% | +99.66% | +164.71% | 801M | |
| -1.01% | +5.13% | +58.93% | +120.37% | 1,144B | |
| -0.61% | +1.52% | +34.34% | +70.28% | 625B | |
| -1.48% | +0.47% | +23.08% | +96.78% | 511B | |
| +0.54% | +8.95% | +39.45% | +64.02% | 377B | |
| +1.07% | +1.70% | +71.06% | +45.02% | 366B | |
| +0.30% | +6.35% | +21.84% | +49.62% | 291B | |
| -0.03% | +6.04% | +0.40% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +60.53% | 237B | |
| -1.88% | +0.02% | +23.77% | +98.00% | 194B | |
| Average | -0.05% | +6.40% | +41.81% | +79.03% | 400.87B | |
| Weighted average by Cap. | -0.42% | +6.91% | +40.80% | +81.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 552M 393M 350M 324M 293M 37.06B 559M 3.88B 1.52B 19.48B 1.47B 1.44B 62.08B | 553M 393M 350M 324M 293M 37.09B 559M 3.89B 1.53B 19.49B 1.47B 1.44B 62.12B |
| Net income | 13.32M 9.47M 8.44M 7.81M 7.07M 893M 13.48M 93.65M 36.75M 470M 35.52M 34.78M 1.5B | 26.36M 18.74M 16.7M 15.46M 13.99M 1.77B 26.68M 185M 72.75M 930M 70.31M 68.85M 2.96B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | $11.70 | +2.18% | 70,523 |
| 26-10-20 | $11.45 | +1.24% | 48,483 |
| 26-10-19 | $11.31 | +2.45% | 93,763 |
| 26-10-16 | $11.04 | +2.22% | 82,225 |
| 26-10-15 | $10.80 | +1.79% | 47,766 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GUD Stock
Select your edition
All financial news and data tailored to specific country editions
